| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a888a536389af4a49ebdc2c36de65848 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-745 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2020-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17c5c26c058667b9718c4d1b08fc83e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab00ed6b9da9dd6ab6d5ec35d5b0f5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f44577d1e63291a1f15710b18d5c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63eba061229c78a83cac5a85a086333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_649dcc81b8aa52502b6c85eac4cf1975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a7b54eb1541f2b61923b67aff9c972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e0e7a1811c1e224b658bf06e41aa2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dce9fc64f2a3dd14e58a21881ff584c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35556ae1956b6daf3e0891f75bf45a0f |
| publicationDate |
2020-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020140569-A1 |
| titleOfInvention |
Binding agent and assay for pivka |
| abstract |
The present disclosure relates to specific binding agents binding to different PIVKA-II forms as compared to antibodies known so far in the art. The present disclosure also relates to methods of using the specific binding agents to detect the presence of PIVKA-II. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116041525-A |
| priorityDate |
2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |